Cabaletta Bio (CABA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CABA Cabaletta Bio

Watchlist

3.550
-0.240-6.33%

Close Oct 31 16:00 ET

3.480
-0.070-1.97%

Post 19:59 ET

173.41MMarket Cap-1858P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

We're Not Very Worried About Cabaletta Bio's (NASDAQ:CABA) Cash Burn Rate
Yahoo FinanceOct 30 11:16 ET
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings
Yahoo FinanceOct 17 15:06 ET
Kyverna, Cabaletta Started at Buys by UBS on CAR T Therapy Potential
Seeking AlphaOct 10 14:04 ET
UBS Initiates Cabaletta Bio(CABA.US) With Buy Rating, Announces Target Price $10
Moomoo NewsOct 10 06:31 ET · Ratings
Cabaletta Bio Initiated With a Buy at UBS
TipRanksOct 10 05:45 ET · Ratings
Cabaletta Bio Outlines Future Trials and Development Strategy
TipRanksOct 7 06:30 ET

Comments

$Cabaletta Bio (CABA.US)$ poor stock … not growing at all

$Cabaletta Bio (CABA.US)$ what happened to it … no improvement at all

$Cabaletta Bio (CABA.US)$
Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024
Cabaletta Bio (Nasdaq: CABA) announced two presentations at the upcoming American College of Rheumatology (ACR) Convergence 2024, featuring new and updated clinical data on CABA-201, their 4-1BB-containing fully human CD19-CAR T cell investigational therapy. The presentations will cover:
1. An oral presentation on the safety and efficacy of C...

frogoracletrading

$CABA Support / Resistance Levels

Testing the bottom of the GAP at 4.82. Here are the levels to keep on watch.
Larger Image: tradingview.com...
$Cabaletta Bio (CABA.US)$

$CABA Support / Resistance Levels

3

Biotech Stock News 3/20

$Annovis Bio (ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies (TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals (TFFP.US)$ 14% Clinical programs update
$Jaguar Health (JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin (SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems (DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences (SLS.US)$ 0% Closes $20M offering & private placement
$Immunic (IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics (NRIX.US)$ 0...

11

1

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data